Nanjing CompTECH Composites Corporation

SZSE:301591 Stock Report

Market Cap: CN¥3.2b

Nanjing CompTECH Composites Past Earnings Performance

Past criteria checks 1/6

Nanjing CompTECH Composites has been growing earnings at an average annual rate of 0.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 8.8% per year. Nanjing CompTECH Composites's return on equity is 8.7%, and it has net margins of 18%.

Key information

0.7%

Earnings growth rate

-15.4%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate8.8%
Return on equity8.7%
Net Margin18.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Sep 02
Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Recent updates

Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Sep 02
Why Nanjing CompTECH Composites' (SZSE:301591) Shaky Earnings Are Just The Beginning Of Its Problems

Revenue & Expenses Breakdown

How Nanjing CompTECH Composites makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:301591 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24419755025
30 Jun 24403714824
31 Mar 24390734522
31 Dec 23390754122
01 Jan 23372733919
31 Dec 1613315400
31 Dec 1513228210
31 Dec 1412030190

Quality Earnings: 301591 has a high level of non-cash earnings.

Growing Profit Margin: 301591's current net profit margins (18%) are lower than last year (19.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 301591's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 301591's past year earnings growth to its 5-year average.

Earnings vs Industry: 301591 earnings growth over the past year (0.7%) exceeded the Chemicals industry -5.3%.


Return on Equity

High ROE: 301591's Return on Equity (8.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies